{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:33:20Z","timestamp":1782923600823,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2018YFE0208000"],"award-info":[{"award-number":["2018YFE0208000"]}]},{"name":"the Key-Area Research and Development Program of Guangdong Province","award":["2018B020241002"],"award-info":[{"award-number":["2018B020241002"]}]},{"name":"the Key Research and Development Program for the 14th Five-Year Plan from the Ministry of Science and Technology, China","award":["20SWAQX02"],"award-info":[{"award-number":["20SWAQX02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chikungunya virus (CHIKV) is a re-emerged mosquito-borne alphavirus that can cause musculoskeletal diseases, imposing a substantial threat to public health globally. High-affinity antibodies are need\u00a0for diagnosis and treatment of\u00a0CHIKV infections. As a potential diagnostic and therapeutic agent, the\u00a0multivalent VHH antibodies is a promising tookit\u00a0in nanomedicine. Here, we developed potent multivalent VHH antibodies from an alpaca na\u00efve phage display library targeting the E2 glycoprotein of the CHIKV virus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the present\u00a0study, we generated 20 VHH antibodies using a na\u00efve phage display library for binders to the CHIKV E2 glycoprotein. Of these, multivalent VHH antibodies Nb-2E8 and Nb-3C5 had specific high-affinity binding to E2 protein within the nanomolar range. The equilibrium dissociation constant (KD) was between\u00a02.59\u201320.7\u00a0nM, which was 100-fold stronger than the monovalent antibodies\u2019 affinity. Moreover, epitope mapping showed that Nb-2E8 and Nb-3C5 recognized different linear epitopes located on the E2 glycoprotein domain C and A, respectively. A facile protocol of sandwich ELISA was established using BiNb-2E8 as a capture antibody and HRP-conjugated BiNb-3C5 as a detection antibody. A good linear correlation was achieved between the <jats:italic>OD<\/jats:italic><jats:sub><jats:italic>450<\/jats:italic><\/jats:sub> value and the E2 protein concentration in the 5\u20131000\u00a0ng\/mL range (<jats:italic>r<\/jats:italic>\u2009=\u20090.9864, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), indicating its potential for quantitative detection of the\u00a0E2 protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared to monovalent antibodies,\u00a0multivalent VHH antibodies Nb-2E8 and Nb-3C5 showed high affinity and are\u00a0potential\u00a0candidates for diagnostic applications to better\u00a0detect CHIKV virions in sera.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-022-01417-6","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T13:03:34Z","timestamp":1652533414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca na\u00efve phage display library"],"prefix":"10.1186","volume":"20","author":[{"given":"Qianlin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingsong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"issue":"2","key":"1417_CR1","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","volume":"4","author":"T Couderc","year":"2008","unstructured":"Couderc T, Chr\u00e9tien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despr\u00e8s P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4(2):e29.","journal-title":"PLoS Pathog"},{"issue":"9816","key":"1417_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(11)60281-X","volume":"379","author":"FJ Burt","year":"2012","unstructured":"Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet. 2012;379(9816):662\u201371.","journal-title":"Lancet"},{"issue":"1","key":"1417_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ijmr.IJMR_204_19","volume":"151","author":"P Joshi","year":"2020","unstructured":"Joshi P, Yadav P, Mourya D, Sahare L, Ukey M, Khedekar R, Patil D, Barde PV. Laboratory surveillance of Chikungunya in Madhya Pradesh, India (2016\u20132017). Indian J Med Res. 2020;151(1):87\u201392.","journal-title":"Indian J Med Res"},{"key":"1417_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12916-015-0348-x","volume":"13","author":"MR Nunes","year":"2015","unstructured":"Nunes MR, Faria NR, de Vasconcelos JM, Golding N, Kraemer MU, de Oliveira LF, Azevedo Rdo S, da Silva DE, da Silva EV, da Silva SP, Carvalho VL, Coelho GE, Cruz AC, Rodrigues SG, Vianez JL Jr, Nunes BT, Cardoso JF, Tesh RB, Hay SI, Pybus OG, Vasconcelos PF. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med. 2015;13:102.","journal-title":"BMC Med"},{"issue":"41","key":"1417_CR5","doi-asserted-by":"publisher","first-page":"20929","DOI":"10.2807\/1560-7917.ES2014.19.41.20929","volume":"19","author":"A Roth","year":"2014","unstructured":"Roth A, Mercier A, Lepers C, Hoy D, Duituturaga S, Benyon E, Guillaumot L, Souares Y. Concurrent outbreaks of dengue, chikungunya and Zika virus infections\u2014an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012\u20132014. Euro Surveill. 2014;19(41):20929.","journal-title":"Euro Surveill"},{"issue":"3","key":"1417_CR6","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1371\/journal.pmed.0050060","volume":"5","author":"P G\u00e9rardin","year":"2008","unstructured":"G\u00e9rardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Lenglet Y, Touret Y, Bouveret A, Grivard P, Le Roux K, Blanc S, Schuffenecker I, Couderc T, Arenzana-Seisdedos F, Lecuit M, Robillard PY. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La R\u00e9union. PLoS Med. 2008;5(3):e60.","journal-title":"PLoS Med"},{"issue":"3","key":"1417_CR7","doi-asserted-by":"publisher","first-page":"e2124","DOI":"10.1371\/journal.pntd.0002124","volume":"7","author":"SW Metz","year":"2013","unstructured":"Metz SW, Gardner J, Geertsema C, Le TT, Goh L, Vlak JM, Suhrbier A, Pijlman GP. Effective Chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis. 2013;7(3):e2124.","journal-title":"PLoS Negl Trop Dis"},{"key":"1417_CR8","doi-asserted-by":"publisher","first-page":"e00435","DOI":"10.7554\/eLife.00435","volume":"2","author":"S Sun","year":"2013","unstructured":"Sun S, Xiang Y, Akahata W, Holdaway H, Pal P, Zhang X, Diamond MS, Nabel GJ, Rossmann MG. Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization. Elife. 2013;2:e00435.","journal-title":"Elife"},{"issue":"3","key":"1417_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1099\/jgv.0.001212","volume":"100","author":"SF Cotmore","year":"2019","unstructured":"Cotmore SF, Agbandje-McKenna M, Canuti M, Chiorini JA, Eis-Hubinger AM, Hughes J, Mietzsch M, Modha S, Ogliastro M, P\u00e9nzes JJ, Pintel DJ, Qiu J, Soderlund-Venermo M, Tattersall P, Tijssen P, Ictv Report Consortium. ICTV virus taxonomy profile: parvoviridae. J Gen Virol. 2019;100(3):367\u20138.","journal-title":"J Gen Virol"},{"issue":"7324","key":"1417_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature09555","volume":"468","author":"JE Voss","year":"2010","unstructured":"Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature. 2010;468(7324):709\u201312.","journal-title":"Nature"},{"issue":"3","key":"1417_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.chom.2020.01.008","volume":"27","author":"AS Kim","year":"2020","unstructured":"Kim AS, Zimmerman O, Fox JM, Nelson CA, Basore K, Zhang R, Durnell L, Desai C, Bullock C, Deem SL, Oppenheimer J, Shapiro B, Wang T, Cherry S, Coyne CB, Handley SA, Landis MJ, Fremont DH, Diamond MS. An evolutionary insertion in the Mxra8 receptor-binding site confers resistance to alphavirus infection and pathogenesis. Cell Host Microbe. 2020;27(3):428-440.e9.","journal-title":"Cell Host Microbe"},{"issue":"7706","key":"1417_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang R, Kim AS, Fox JM, Nair S, Basore K, Klimstra WB, Rimkunas R, Fong RH, Lin H, Poddar S, Crowe JE Jr, Doranz BJ, Fremont DH, Diamond MS. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature. 2018;557(7706):570\u20134.","journal-title":"Nature"},{"issue":"6428","key":"1417_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 1993;363(6428):446\u20138.","journal-title":"Nature"},{"issue":"1","key":"1417_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41467-017-00448-0","volume":"8","author":"NJ Huang","year":"2017","unstructured":"Huang NJ, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, Dong M, Shoemaker CB, Lodish HF. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun. 2017;8(1):423.","journal-title":"Nat Commun"},{"issue":"1","key":"1417_CR15","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1038\/s41467-020-19884-6","volume":"11","author":"SA Nordeen","year":"2020","unstructured":"Nordeen SA, Andersen KR, Knockenhauer KE, Ingram JR, Ploegh HL, Schwartz TU. A nanobody suite for yeast scaffold nucleoporins provides details of the nuclear pore complex structure. Nat Commun. 2020;11(1):6179.","journal-title":"Nat Commun"},{"issue":"10","key":"1417_CR16","doi-asserted-by":"publisher","first-page":"e02438","DOI":"10.1128\/JVI.02438-20","volume":"95","author":"H Ma","year":"2021","unstructured":"Ma H, Zeng W, Meng X, Huang X, Yang Y, Zhao D, Zhou P, Wang X, Zhao C, Sun Y, Wang P, Ou H, Hu X, Xiang Y, Jin T. Potent neutralization of SARS-CoV-2 by hetero-bivalent alpaca nanobodies targeting the spike receptor-binding domain. J Virol. 2021;95(10):e02438-e2520.","journal-title":"J Virol"},{"key":"1417_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1146\/annurev-immunol-042617-053327","volume":"36","author":"JR Ingram","year":"2018","unstructured":"Ingram JR, Schmidt FI, Ploegh HL. Exploiting nanobodies\u2019 singular traits. Annu Rev Immunol. 2018;36:695\u2013715.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1417_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.01802-15","volume":"60","author":"L Detalle","year":"2015","unstructured":"Detalle L, Stohr T, Palomo C, Piedra PA, Gilbert BE, Mas V, Millar A, Power UF, Stortelers C, Allosery K, Melero JA, Depla E. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. Antimicrob Agents Chemother. 2015;60(1):6\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1417_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/protein\/gzv020","volume":"28","author":"O Crasson","year":"2015","unstructured":"Crasson O, Rhazi N, Jacquin O, Freichels A, J\u00e9r\u00f4me C, Ruth N, Galleni M, Fil\u00e9e P, Vandevenne M. Enzymatic functionalization of a nanobody using protein insertion technology. Protein Eng Des Sel. 2015;28(10):451\u201360.","journal-title":"Protein Eng Des Sel"},{"issue":"42","key":"1417_CR20","doi-asserted-by":"publisher","first-page":"13245","DOI":"10.1021\/jp403425z","volume":"117","author":"E De Genst","year":"2013","unstructured":"De Genst E, Chan PH, Pardon E, Hsu SD, Kumita JR, Christodoulou J, Menzer L, Chirgadze DY, Robinson CV, Muyldermans S, Matagne A, Wyns L, Dobson CM, Dumoulin M. A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. J Phys Chem B. 2013;117(42):13245\u201358.","journal-title":"J Phys Chem B"},{"issue":"1","key":"1417_CR21","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/22221751.2020.1768806","volume":"9","author":"J Dong","year":"2020","unstructured":"Dong J, Huang B, Jia Z, Wang B, Gallolu Kankanamalage S, Titong A, Liu Y. Development of multi-specific humanized llama antibodies blocking SARS-CoV-2\/ACE2 interaction with high affinity and avidity. Emerg Microbes Infect. 2020;9(1):1034\u20136.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"1417_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","volume":"27","author":"J Huo","year":"2020","unstructured":"Huo J, Le Bas A, Ruza RR, Duyvesteyn HME, Mikolajek H, Malinauskas T, Tan TK, Rijal P, Dumoux M, Ward PN, Ren J, Zhou D, Harrison PJ, Weckener M, Clare DK, Vogirala VK, Radecke J, Moyni\u00e9 L, Zhao Y, Gilbert-Jaramillo J, Knight ML, Tree JA, Buttigieg KR, Coombes N, Elmore MJ, Carroll MW, Carrique L, Shah PNM, James W, Townsend AR, Stuart DI, Owens RJ, Naismith JH. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020;27(9):846\u201354.","journal-title":"Nat Struct Mol Biol"},{"key":"1417_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12951-015-0091-7","volume":"13","author":"J Yan","year":"2015","unstructured":"Yan J, Wang P, Zhu M, Li G, Rom\u00e3o E, Xiong S, Wan Y. Characterization and applications of nanobodies against human procalcitonin selected from a novel na\u00efve nanobody phage display library. J Nanobiotechnology. 2015;13:33.","journal-title":"J Nanobiotechnology"},{"key":"1417_CR24","doi-asserted-by":"publisher","first-page":"553837","DOI":"10.3389\/fcimb.2020.553837","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zhou L, Du K, Zhang Y, Wang J, Chen L, Lyu Y, Li J, Liu H, Huo J, Li F, Wang J, Sang P, Lin S, Xiao Y, Zhang K, He K. Foundation and clinical evaluation of a new method for detecting SARS-CoV-2 antigen by fluorescent microsphere immunochromatography. Front Cell Infect Microbiol. 2020;10:553837.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"1417_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20151790","volume":"213","author":"FI Schmidt","year":"2016","unstructured":"Schmidt FI, Lu A, Chen JW, Ruan J, Tang C, Wu H, Ploegh HL. A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly. J Exp Med. 2016;213(5):771\u201390.","journal-title":"J Exp Med"},{"issue":"1","key":"1417_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12951-021-00768-w","volume":"19","author":"Q Lu","year":"2021","unstructured":"Lu Q, Zhang Z, Li H, Zhong K, Zhao Q, Wang Z, Wu Z, Yang D, Sun S, Yang N, Zheng M, Chen Q, Long C, Guo W, Yang H, Nie C, Tong A. Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein. J Nanobiotechnology. 2021;19(1):33.","journal-title":"J Nanobiotechnology"},{"issue":"44","key":"1417_CR27","doi-asserted-by":"publisher","first-page":"27637","DOI":"10.1073\/pnas.2008051117","volume":"117","author":"QF Zhou","year":"2020","unstructured":"Zhou QF, Fox JM, Earnest JT, Ng TS, Kim AS, Fibriansah G, Kostyuchenko VA, Shi J, Shu B, Diamond MS, Lok SM. Structural basis of Chikungunya virus inhibition by monoclonal antibodies. Proc Natl Acad Sci U S A. 2020;117(44):27637\u201345.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"1417_CR28","doi-asserted-by":"publisher","first-page":"e00252","DOI":"10.1128\/JVI.00252-20","volume":"94","author":"U Tumkosit","year":"2020","unstructured":"Tumkosit U, Siripanyaphinyo U, Takeda N, Tsuji M, Maeda Y, Ruchusatsawat K, Shioda T, Mizushima H, Chetanachan P, Wongjaroen P, Matsuura Y, Tatsumi M, Tanaka A. Anti-Chikungunya virus monoclonal antibody that inhibits viral fusion and release. J Virol. 2020;94(19):e00252-e320.","journal-title":"J Virol"},{"key":"1417_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans S. Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013;82:775\u201397.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1417_CR30","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41467-021-22732-w","volume":"12","author":"JE Shin","year":"2021","unstructured":"Shin JE, Riesselman AJ, Kollasch AW, McMahon C, Simon E, Sander C, Manglik A, Kruse AC, Marks DS. Protein design and variant prediction using autoregressive generative models. Nat Commun. 2021;12(1):2403.","journal-title":"Nat Commun"},{"issue":"5","key":"1417_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jmb.2004.05.051","volume":"340","author":"CV Lee","year":"2004","unstructured":"Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol. 2004;340(5):1073\u201393.","journal-title":"J Mol Biol"},{"key":"1417_CR32","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3389\/fimmu.2017.01989","volume":"8","author":"T Eden","year":"2018","unstructured":"Eden T, Menzel S, Wesolowski J, Bergmann P, Nissen M, Dubberke G, Seyfried F, Albrecht B, Haag F, Koch-Nolte F. A cDNA immunization strategy to generate nanobodies against membrane proteins in native conformation. Front Immunol. 2018;8:1989.","journal-title":"Front Immunol"},{"issue":"9","key":"1417_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","volume":"7","author":"S Muyldermans","year":"1994","unstructured":"Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng. 1994;7(9):1129\u201335.","journal-title":"Protein Eng"},{"issue":"1","key":"1417_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pep.2005.03.016","volume":"43","author":"TR Butt","year":"2005","unstructured":"Butt TR, Edavettal SC, Hall JP, Mattern MR. SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif. 2005;43(1):1\u20139.","journal-title":"Protein Expr Purif"},{"key":"1417_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-59745-566-4_20","volume":"497","author":"T Panavas","year":"2009","unstructured":"Panavas T, Sanders C, Butt TR. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. Methods Mol Biol. 2009;497:303\u201317.","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"1417_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:JSFG.0000029237.70316.52","volume":"5","author":"MP Malakhov","year":"2004","unstructured":"Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics. 2004;5(1\u20132):75\u201386.","journal-title":"J Struct Funct Genomics"},{"issue":"2","key":"1417_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00253-008-1655-3","volume":"81","author":"T Ye","year":"2008","unstructured":"Ye T, Lin Z, Lei H. High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli. Appl Microbiol Biotechnol. 2008;81(2):311\u20137.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"1417_CR38","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.peptides.2010.08.008","volume":"31","author":"B Bommarius","year":"2010","unstructured":"Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H, Jaeger KE, Hancock RE, Kalman D. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides. 2010;31(11):1957\u201365.","journal-title":"Peptides"},{"issue":"1","key":"1417_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00253-011-3864-4","volume":"96","author":"X Liu","year":"2012","unstructured":"Liu X, Chen Y, Wu X, Li H, Jiang C, Tian H, Tang L, Wang D, Yu T, Li X. SUMO fusion system facilitates soluble expression and high production of bioactive human fibroblast growth factor 23 (FGF23). Appl Microbiol Biotechnol. 2012;96(1):103\u201311.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1417_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2018.07.002","volume":"157","author":"AS Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez AS, Guimar\u00e3es Assmann AL, Romero Ramos CR, Quelopana MM, Aleixo Silva AC, Thomaz-Soccol V. Recombinant mutagenic 3ABC protein and monoclonal antibody for quality-control testing in foot-and-mouth disease vaccines. Antiviral Res. 2018;157:93\u2013101.","journal-title":"Antiviral Res"},{"issue":"1","key":"1417_CR41","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1038\/s41467-020-18387-8","volume":"11","author":"X Chi","year":"2020","unstructured":"Chi X, Liu X, Wang C, Zhang X, Li X, Hou J, Ren L, Jin Q, Wang J, Yang W. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain. Nat Commun. 2020;11(1):4528.","journal-title":"Nat Commun"},{"issue":"2","key":"1417_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/ijms21020636","volume":"21","author":"M Spodzieja","year":"2020","unstructured":"Spodzieja M, Kuncewicz K, Sieradzan A, Karczy\u0144ska A, Iwaszkiewicz J, Cesson V, W\u0119grzyn K, Zhukov I, Maszota-Zieleniak M, Michielin O, Speiser DE, Zoete V, Derr\u00e9 L, Rodziewicz-Motowid\u0142o S. Disulfide-linked peptides for blocking BTLA\/HVEM binding. Int J Mol Sci. 2020;21(2):636.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1417_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nbt1142","volume":"23","author":"P Holliger","year":"2005","unstructured":"Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol. 2005;23(9):1126\u201336.","journal-title":"Nat Biotechnol"},{"key":"1417_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/0976-9668.71675","volume":"1","author":"H Attarwala","year":"2010","unstructured":"Attarwala H. Role of antibodies in cancer targeting. J Nat Sci Biol Med. 2010;1:53\u20136.","journal-title":"J Nat Sci Biol Med"},{"issue":"1","key":"1417_CR45","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1038\/s41467-018-07129-6","volume":"9","author":"SA Farhadi","year":"2018","unstructured":"Farhadi SA, Bracho-Sanchez E, Fettis MM, Seroski DT, Freeman SL, Restuccia A, Keselowsky BG, Hudalla GA. Locally anchoring enzymes to tissues via extracellular glycan recognition. Nat Commun. 2018;9(1):4943.","journal-title":"Nat Commun"},{"key":"1417_CR46","doi-asserted-by":"crossref","unstructured":"Hartati L, Bakti D, Tantawi AR, Lisnawita. Detection of virus causes papaya ringspot virus\u2014with the DAS-Elisa (Double Antibody Sandwich-Enzyme-Linked Immunosorbent Assay) method at different levels in North Sumatra. Earth Environ Sci. 2020;454: 012182.","DOI":"10.1088\/1755-1315\/454\/1\/012182"},{"key":"1417_CR47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/IJN.S150336","volume":"13","author":"C Wang","year":"2018","unstructured":"Wang C, Gu B, Liu Q, Pang Y, Xiao R, Wang S. Combined use of vancomycin-modified Ag-coated magnetic nanoparticles and secondary enhanced nanoparticles for rapid surface-enhanced Raman scattering detection of bacteria. Int J Nanomedicine. 2018;13:1159\u201378.","journal-title":"Int J Nanomedicine"},{"key":"1417_CR48","doi-asserted-by":"publisher","first-page":"540248","DOI":"10.3389\/fvets.2020.540248","volume":"7","author":"B Fan","year":"2020","unstructured":"Fan B, Sun J, Zhu L, Zhou J, Zhao Y, Yu Z, Sun B, Guo R, He K, Li B. Development of a novel double antibody sandwich quantitative enzyme-linked immunosorbent assay for detection of porcine epidemic diarrhea virus antigen. Front Vet Sci. 2020;7:540248.","journal-title":"Front Vet Sci."},{"issue":"1","key":"1417_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/1348-0421.12751","volume":"64","author":"SY Choi","year":"2020","unstructured":"Choi SY, Rhie GE, Jeon JH. Development of a double-antibody sandwich ELISA for sensitive detection of Yersinia pestis. Microbiol Immunol. 2020;64(1):72\u20135.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"1417_CR50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/CBM-160649","volume":"17","author":"J Wang","year":"2016","unstructured":"Wang J, Zhang S, Ni W, Zhai X, Xie F, Yuan H, Gao S, Tai G. Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients. Cancer Biomark. 2016;17(4):369\u201376.","journal-title":"Cancer Biomark"},{"issue":"4","key":"1417_CR51","doi-asserted-by":"publisher","first-page":"e1003312","DOI":"10.1371\/journal.ppat.1003312","volume":"9","author":"P Pal","year":"2013","unstructured":"Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MK, Smit JM, Fremont DH, Pierson TC, Heise MT, Diamond MS. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog. 2013;9(4):e1003312.","journal-title":"PLoS Pathog"},{"issue":"12","key":"1417_CR52","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","volume":"190","author":"FM Lum","year":"2013","unstructured":"Lum FM, Teo TH, Lee WW, Kam YW, R\u00e9nia L, Ng LF. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol. 2013;190(12):6295\u2013302.","journal-title":"J Immunol"},{"key":"1417_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jviromet.2013.10.015","volume":"195","author":"CL Chua","year":"2014","unstructured":"Chua CL, Chan YF, Sam IC. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein. J Virol Methods. 2014;195:126\u201333.","journal-title":"J Virol Methods"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01417-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01417-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T14:11:48Z","timestamp":1652537508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01417-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01417-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"29 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The serum samples of CHIKV patients were obtained from the Center for Disease Control and Prevention of Southern Theater Command. All patients have agreed to share their serum samples by informed consent, and the study was approved by the ethics committee of Sun-Yet Sen university.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}